Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
HUMAN C1 INHIBITOR PRODUCED IN THE MILK OF TRANSGENIC MAMMALS
No-Receipt date
2010-04242 - 23/12/2010
No-Filing date
20100800032 - 23/12/2010
No-Granting date
8000353 - 31/05/2011
No-EPO application date
-
No-EPO granting date
-
Gazette No-Publication date of application
4/2011 - 13/05/2011
Gazette No-Publication date of granted patent
5/2011 - 14/06/2011
Expiration date
04/11/2025
Kind of title
Supplementary Protection Certificate for Medicinal Products
Legal status
VALID
Priorities
US179310 P31/01/2000/US
EP0020032031/01/2000/EP
US187580 P07/03/2000/US
EP0020081007/03/2000/EP
Active Substance of Supplementary Certificates
-
IPC Classification
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20200900012
[SPC]
20080400556
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
233782
PHARMING INTELLECTUAL PROPERTY B.V.
P.O. BOX 451
2330 AL LEIDEN
NETHERLANDS
Inventors
Code
Firstname
Surname
550734
NUIJENS, JOHANNES, HENRICUS
550735
VAN VEEN, HENRICUS, ANTONIUS
550736
PIEPER, FRANK, R.
550737
HEUS, JORIS, JAN
Representatives
Code
Firstname
Surname
Address
Town
Zip
956
NIKOLAOS
LYMPERIS
STOURNARA 37
ATHINA (ATTIKIS)
10682
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2832
NIKOLAOS
LYMPERIS
STOURNARA 37
ATHINA (ATTIKIS)
10682
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
8/23/2021 12:00:00 AM
Διάφορες Μεταβολές (70004)
Διόρθωση στην ημερομηνία λήξεως από : 28.10.2025 σε : 04.11.2025 σύμφωνα με την από 06.10.2015 απόφαη του Δικαστηρίου Ευρωπαικής Ένωσης σχετικά με την υπόθεση C-471/14.
Payments history
5 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).